At the 25 min mark of the much touted video our CMO, Steven Becker, poses the rhetorical question are the changes observed in the 010 and 011 trials of a clinical magnitute that would engage the interest of Big Pharma's and goes on the answer that question saying that we don't know but we didn't knock it out of the park.
This from the man responsible for overseeing the design and analysis of the trial results. But don't worry he says we could have a crack at cancer.
Worth a listen for any prospective investors.You'll be filled with confidence, Lol.
Lots wrong now.
BIT Price at posting:
2.7¢ Sentiment: Hold Disclosure: Held
